Holen Sie sich die Stockscreener-App
26.56
1.37%
-0.37
Maze Therapeutics Inc Aktie (MAZE) Neueste Nachrichten
Maze Therapeutics (MAZE) CSBO exercises options, sells 7,500 shares under 10b5-1 plan - Stock Titan
MAZE Stock Price, Quote & Chart | MAZE THERAPEUTICS INC (NASDAQ:MAZE) - ChartMill
MAZE SEC FilingsMaze Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
After plunging 30.8% in 4 weeks, here's why the trend might reverse for Maze Therapeutics, Inc. (MAZE) - MSN
Maze Therapeutics (NASDAQ: MAZE) details 2026 proxy, board slate and executive pay - Stock Titan
Maze Therapeutics (MAZE) price target increased by 19.51% to 61.71 - MSN
Maze Therapeutics Stock Surges with 150 Percent Upside Potential - HarianBasis.co
What Makes Maze Therapeutics (MAZE) One of the Best Oversold Small-Cap Stocks to Buy - Yahoo Finance
5 Oversold Small Cap Stocks to Buy Now - Insider Monkey
Maze Therapeutics shares surge after positive Phase 2 data for MZE829 - MSN
Maze Therapeutics Raises Fresh Capital As R&D Plans And Valuation Diverge - Sahm
Maze Therapeutics falls despite positive mid-stage trial data for lead asset - MSN
Maze Therapeutics prices $150M equity offering - MSN
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN
Maze Therapeutics prices $150 million equity offering - TipRanks
Maze Therapeutics prices $150M registered offering; expects ~$144.7M net proceeds, funds into 2029 - TradingView
[8-K] Maze Therapeutics, Inc. Reports Material Event - Stock Titan
[424B5] Maze Therapeutics, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
Maze Therapeutics (NASDAQ:MAZE) Shares Gap UpHere's Why - MarketBeat
Maze Therapeutics (MAZE) Stock: Momentum Shift Insight (Rocket Higher) 2026-04-22Professional Trade Ideas - UBND thành phố Hải Phòng
MAZE Secures Investment from Notable Funds - GuruFocus
Maze Therapeutics priced offering of 5.54M shares of common stock at $23.50 - TipRanks
Maze Therapeutics Intends to Use Any Net Proceeds From Offering to Advance R&D of Its Product Candidates >MAZE - Moomoo
Maze Therapeutics Prices Public Offering of 5,540,000 Shares at $23.50 Per Share, Aiming for $150 Million in Gross Proceeds - Quiver Quantitative
Maze Therapeutics announces $150 million registered offering - marketscreener.com
Maze Therapeutics Announces $150 Million Registered Offering - TradingView
Fenwick Represents Maze Therapeutics in $150M Underwritten Offering - fenwick.com
239,994 Shares in Maze Therapeutics, Inc. $MAZE Acquired by Mass General Brigham Inc - MarketBeat
Truist Updates Maze Therapeutics, Inc. (MAZE) Model for Share Count and Warrant Impact - Insider Monkey
Is Maze Therapeutics (MAZE) stock holding its gains (-0.96%) 2026-04-20High Volume Stocks - UBND thành phố Hải Phòng
Maze Therapeutics (NASDAQ:MAZE) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a 139.88% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Immuneering (IMRX) and Maze Therapeutics, Inc. (MAZE) - The Globe and Mail
Maze Therapeutics (NASDAQ:MAZE) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Maze Therapeutics Inc. places pharma partnerships in focus as President of R and D moderates Boston panel - Traders Union
What analysts say about Maze Therapeutics Inc stockWeekly Gains Report & Trade Opportunity Analysis Reports - baoquankhu1.vn
MAZE Options Volatility — NASDAQ:MAZE - TradingView
MAZE Options Chain — NASDAQ:MAZE - TradingView
MAZE News Today | Why did Maze Therapeutics stock go up today? - MarketBeat
Gainers Report: Is CLVT a play on infrastructure spending2026 Selloffs & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Assessing Maze Therapeutics (MAZE) Valuation After Strong One Year Return And Recent Pullbacks - Sahm
Rally Mode: Whats the fair value of Maze Therapeutics Inc stockWeekly Loss Report & Precise Trade Entry Recommendations - baoquankhu1.vn
HC Wainwright Issues Optimistic Estimate for MAZE Earnings - MarketBeat
Maze Therapeutics, Inc. (NASDAQ:MAZE) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Maze Therapeutics, Inc. (MAZE) stock price, news, quote and history - Yahoo Finance Australia
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
San Francisco Pharma Co.'s HORIZON Phase 2 Data Validates APOL1 Path to Pivotal Trial - Streetwise Reports
Are insiders buying or selling Maze Therapeutics (MAZE) Stock | Price at $28.23, Down 0.35%Trending Momentum Stocks - Xã Vĩnh Công
Here is why Maze Therapeutics (MAZE) is Among the Top 8 Oversold Strong Buy-Rated Stocks - Insider Monkey
Pharma News: What analysts say about Maze Therapeutics Inc stock2026 Review & Daily Stock Momentum Reports - baoquankhu1.vn
Edison Issues Report on MindMaze Therapeutics (MMTX) - Yahoo Finance
8 Most Oversold Strong Buy-Rated Stocks to Invest In - Insider Monkey
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):